SEARCH

SEARCH BY CITATION

References

  • Akademiska Sjukhuset (2002): Prislista 2002. Sluten och Öppen vård. [Price list for 2002 for Akademiska University Hospital.]
  • Bonomi L, Marchini G, Marraffa M & Morbio R (2001): The relationship between intraocular pressure and glaucoma in a defined population. Data from the Egna-Neumarkt Glaucoma Study. Ophthal-mologica 215: 3438.
  • Caisse Nationale d'Assurance Maladie (2002): Conventions et tariffs.http://www.cnamts.fr. [Accessed November 2002.]
  • Coffey M, Reidy A, Wormald R, Xian WX, Wright L & Courtney P (1993): Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 77: 1721.
  • Coyle D & Drummond M (1995): The economic burden of glaucoma in the UK. The need for a far-sighted policy. Pharmaco- economics 7: 484489.
  • Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE & De Jong PT (1993): The prevalence of primary open-angle glaucoma in a population-based study in the Netherlands. The Rotterdam Study. Ophthalmology 101: 18511855.
  • European Glaucoma Society (EGS) (1998): 1998 Terminology and Guidelines for Glaucoma. Savona: Editrice DOGMA.
  • FASS (2002): Läkemedelsfakta.http://www.fass.se/LIF/produktfakta/produktfakta.jsp. [Accessed November 2002.]
  • Federation of County Councils (1999): Cost per Patient, Bed-day, Physician Visit etc. in 1996. Stockholm: Federation of County Councils.
  • Glaucoma Laser Trial (GLT) & Glaucoma Laser Trial Follow-up Study (1995): 7. Results. Am J Ophthalmol 120: 718731.
  • Henriksson F, Fredrikson S & Jönsson B (2000): Costs, quality of life and disease severity in multiple sclerosis – a population- based cross-sectional study in Sweden. Working paper no. 361. SSE/EFI Working Paper Series in Economics and Finance. Stockholm: Stockholm School of Economics.
  • Jönsson B & Kriegelstein G (1998): Primary open-angle glaucoma. Differences in international treatment patterns and costs. Oxford: Isis Medical Media.
  • Kobelt G, Jönsson L, Gerdtham U & Kriegelstein GK (1998): Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany. Graefes Arch Clin Exp Ophthalmol 236: 811821.
  • Kobelt-Nguyen G, Gerdtham U & Alm A (1998): Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational 2-year chart review of newly diagnosed patients in Sweden and the United States. J Glaucoma 7: 95104.
  • Kocur I & Resnikoff S (2002): Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol 86: 716722.
  • Kroese M, Burton H, Vardy S, Rimmer T & McCarter D (2002): Prevalence of primary open-angle glaucoma in general ophthalmology practice in the United Kingdom. Br J Ophthalmol 86: 978980.
  • Lee PP, Walt JG, Doyle JJ et al. (2005): A multicentre, retrospective pilot study of resource utilization and costs associated with severity of disease in glaucoma. Ophthalmology. In press.
  • Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Casciano JP, Doyle JJ & Evans SJ (2002): Categorizing the progression of glaucoma from pre-diagnosis to end-stage disease by a novel six-point staging system. [Abstract 2160.] 2002 Annual Meeting Abstract and Program Planner. Association for Research in Vision and Ophthalmology. http://www.arvo.org.
  • Musch DC, Lichter PR, Guire KE, Standardi CL & the CIGTS Study Group (1999): The Collaborative Initial Glaucoma Treatment Study. Ophthalmology 106: 653662.
  • Nomenclature Générale des Actes Professi-onnels (2002): Mise à Jour 1–2002. Paris: Union des Casses Nationales de Sécurité Sociale (UCANSS).
  • Norrlands Universitetssjukhus (2002): Prislista år 2002 för Norrlands Universitetssjukhus. [Price list for 2002 from Norrland University Hospital.]
  • Oostenbrink JB, Rutten-van Mölken MPMH & Opdenoordt TS (1999): The treatment of newly diagnosed patients with glaucoma or with ocular hypertension in the Netherlands: an observational study of costs and initial treatment success based on retrospective chart review. Doc Ophthalmol 98: 285299.
  • Oostenbrink JB, Rutten-van Mölken MPMH & Sluyter-Opdenoordt TS (2001): Resource use and costs of patients with glaucoma or ocular hypertension: a 1-year study based on retrospective chart review in the Netherlands. J Glaucoma 10: 184191.
  • Organisation for Economic Co-operation and Development (OECD) (2003): Exchange rates August 2000, national currency to Euro. http://www.oecd.org/dataoecd/55/62/2487525.pdf. [Accessed January 2003.]
  • Programme de Médicalisation des Systèmes d'Information (2002): Coûts de reference. http://www.le-pmsi.fr. [Accessed November 2002.]
  • Quigley HA (1996): Number of people with glaucoma worldwide. Br J Ophthalmol 80: 389393.
  • Södra Sjukvårdsregionen (2002): Prislista för Södra Sjukvårdsregionen 2002. [Price list for 2002 from the southern health care region in Sweden.]http://www.srvn.org/prislista.htm. [Accessed November 2002.]
  • Strutton DR & Walt JG (2004): Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma 13: 221226.
  • Traverso CE, Gandolfi SA, Kelly SP et al. (2003): Estimation of resource utilization associated with glaucoma disease progression in a multinational retrospective study in Europe. [Abstract.] Presented at the American Academy of Ophthalmology 2003 Annual Meeting, November 15–18, 2003, Anaheim, California, USA.
  • Västra Sjukvårdsregionen (2002): Utomlänspriser 2002. För vårdtjänster enligt samverkansavtal om hälso- och sjukvård inom Västra Sjukvårdsregionen. [Price list for 2002 from the western health care region in Sweden.]
  • Vidal (2002): L'information de référence sur les produits de santé. http://www.vidal.fr/recherchemedicament.asp. [Accessed November 2002.]